AwardTape · Defense awards · Medical · Drugs and biologicals · HT941025F0035
HT941025F0035: $44K BPA call to Ino Therapeutics LLC
Ino Therapeutics LLC holds a BPA call from Defense Health Agency with $44K obligated since Oct 2023, against a ceiling of $44K. Latest action Mar 14, 2025.
Inhaled nitric oxide therapeutic gas
| PIID | HT941025F0035 |
|---|---|
| Type | BPA call |
| Parent award | HT941025A0007 |
| Company | Ino Therapeutics LLC |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $44K |
| Total obligated (lifetime) | $44K |
| Ceiling (base and all options) | $44K |
| Base date | Mar 14, 2025 |
| Latest action | Mar 14, 2025 |
| End date | Sep 30, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | MO |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial